ABSTRACT Patients with chronic airflow obstruction were given a three-week course of prednisolone 40 mg per day. The (HPA) function in these patients.
Short high dose courses of corticosteroids are commonly given to patients with chronic airflow obstruction. After such a course, the corticosteroids are either tailed off or stopped abruptly since adrenal function is often assumed to be normal. A recent report has demonstrated depression of adrenal function in cancer patients receiving chemotherapy and short high dose courses of corticosteroids.1 We have studied the time course of response to a short high dose course of prednisolone in patients with chronic airflow obstruction.2 This provided us with an opportunity to study hypothalamic-pituitary-adrenal (HPA) function in these patients.
Methods
All the patients studied had chronic airflow obstruction. None had received corticosteroids within three months of the study and none had cver been on long-term treatment with corticosteriods. In the first part of the study a short tetracosactrin test3 was used to assess adrenal function in eight patients before and after a three-week course of prednisolone 20 mg twice daily. In the short tetracosactrin test a basal plasma cortisol level is measured and followed immediately by an intramuscular injection of 250 jug of synthetic corticotrophin (tetracosactrin). Thirty minutes after the injection of tetracosactrin a blood sample is taken for measurement of plasma cortisol. The first tetracosactrin test was performed on the day before starting prednisolone and the second test performed on the first day after the three-week course of prednisolone 20 mg twice daily.
The results of the first experiment confirmed that both the basal cortisol and the response to tetracosactrin were suppressed, and we went on to investigate the time course of the recovery of the basal cortisol and ACTH levels after a three-week course of prednisolone 40 mg daily (20 mg bd) in a further seven patients. In this second experiment basal cortisol and ACTH levels were measured on two occasions during the week before treatment and again on days 1, 2, 3, 4, and 5 after treatment with prednisolone. Each blood sample was taken between 0800 and 1000. In four of these seven patients a short tetracosactrin test was repeated on day 5 after treatment with prednisolone.
The plasma cortisol concentration was measured by an automated modification4 of the acidfluorescence method of Mattingley.5 The normal range of basal cortisol levels between 0800 and 1000 is 150-700 nmol/l. The normal response 30 minutes after 250 ,ug of tetracosactrin is an increase of not less than 190 nmol/l reaching a minimum of 550 nmol/l. The plasma ACTH concentration was measured by the cytochemical section bioassay method. 
Discussion
Biochemical suppression of adrenal function and adrenal atrophy has previously been shown to occur within five days of a dose of approximately 20 mg prednisolone per day.7 Our results confirm suppression of both the basal cortisol and response to tetracosactrin after a short high dose course of prednisolone. We have also demonstrated that the basal ACTH level is suppressed, a finding which has been assumed but has not been possible to verify accurately previously because of the relative insensitivity of the radioimmunoassay method of measuring ACTH levels.
Recovery of HPA function after long-term treatment with corticosteroids is poorly correlated with duration of therapy.9 10 Graber et all' showed in patients on high doses of corticosteroids for more than one year that the basal cortisol levels 
